Dr. Jatinder Lamba secures UF Research Opportunity Seed Fund Award
This award will go towards developing a relapse response score for AML patients using CRISPR/Cas9 screening.
This award will go towards developing a relapse response score for AML patients using CRISPR/Cas9 screening.
The Children’s Oncology Group has awarded Jatinder Lamba, Ph.D., M.Sc., a $50,000 grant to study the impact of CD33 genetics on pediatric cancer patients.